Browsing: eli lilly
Investor optimism about the pill version of weight-loss injectables being developed by Sam Chun Dang Pharm (SCD) in South Korea…
In this week’s edition of InnovationRx, we look at the price cuts for blockbuster weight-loss drugs, the Forbes 30 Under…
South Korea’s biotech sector is having its moment. Investor optimism about the pipeline of cancer drugs being developed by biotech…
A $2.6 billion licensing and joint research deal with Eli Lilly boosted shares of South Korean biotech company ABL Bio…